A Watershed Moment in Oncology In the summer of 2026, the oncology world collectively held its breath. The announcement from pharmaceutical giants Moderna and Merck wasn’t just another routine press release; it represented a seismic shift in the decades-long war against cancer. Their personalized mRNA vaccine, scientifically designated as intismeran autogene, had accomplished what no mRNA therapy had ever achieved before: it succeeded in a massive, late-stage (Phase 3) clinical trial. For patients battling high-risk melanoma—the deadliest form of skin cancer—this vaccine, when combined with the established immunotherapy drug Keytruda, dramatically reduced the likelihood of the cancer returning. This wasn’t…

The sun hung heavy over Kiirua, Meru County, as a crowd gathered not for a festival, but for something rarer in Kenyan politics: a promise to speak plainly. The occasion was the Linda Mwananchi tour, a grassroots opposition movement steadily making its way across the country in the long shadow of the 2027 General Election. At the centre of it all stood Nairobi Senator Edwin Sifuna, a man known for sharp words and streetwise humor, but on this day his tone was more reflective, almost personal. He had come not to sell impossible dreams, but to offer something more radical:…